@medburnbook https://t.co/hGBsICFLFI
I think about total sign up bonus (miles may be worth more than cash offers), annual fee, and ongoing rewards (eg, air miles vs. 2% cash back). Link as a starter.
If you’re putting thousands on a card, a 2% back card with a sign up bonus may be best.
@sargsyanz@rbganatra I’m guessing here, but maybe with 12 months being the “final analysis” means they’re still at risk of MACE until that time. Then if they’re not followed up and MACE can’t be commented on, they’re censored and assumed to have the event of interest.
📖 This analysis of peer-reviewed reports found that adverse event reporting for #AYAC on cancer #clinicaltrials was poor; given the lack of AE reporting by age, differing side effect profiles in the #AYACSM pop may be missed. ➡️ https://t.co/r8rws0i3Jz @ColeWayant @mroth_MD
Our work on quality of content of oncology news websites just out:
https://t.co/9hid89rKYX
Major team effort led by @NamSharmaMD with input from @AaronGoodman33 @ColeWayant@VPrasadMDMPH, Chris Booth, @KarunNeupaneMD and my wise friend and pt advocate @MyelomaAmateur
🧵👇
Our poster on the quality of content of OncLive and Targeted Oncology.
Meeting @NamSharmaMD for the first time and seeing how eloquently he described our findings almost made me tear up. Such a joy to mentor trainees!
Hoping positive changes can come out of this.
#ASH22
@JeraldAmir You realize you sound like you’re victim blaming here? Your argument is closer to “shouldn’t have dressed like that, what did you expect” than you realize.
I’ll reiterate, the problem is that Primo allegedly exposed himself 9 times. Not that she allowed it 9 times.